Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ADAM15 |
| Upstream (Parents) |
|---|
| (<<) ACTB → ADAM15 |
| (<<) ANKDD1A → ADAM15 |
| (<<) CFL1 → ADAM15 |
| (<<) CYB5R3 → ADAM15 |
| (<<) DHX9 → ADAM15 |
| (<<) EZR → ADAM15 |
| (<<) HPCAL1 → ADAM15 |
| (<<) KCTD5 → ADAM15 |
| (<<) MAPKAP1 → ADAM15 |
| (<<) MAT2A → ADAM15 |
| (<<) PAK4 → ADAM15 |
| (<<) PTPN11 → ADAM15 |
| (<<) RAB5C → ADAM15 |
| (<<) RHOB → ADAM15 |
| (<<) SH3GLB2 → ADAM15 |
| (<<) TAGLN2 → ADAM15 |
| (<<) YWHAE → ADAM15 |
| (<<) YWHAZ → ADAM15 |
| Downstream (Children) |
|---|
| ADAM15 → ARHGEF2 (>>) |
| ADAM15 → ATP2A2 (>>) |
| ADAM15 → CDCP1 (>>) |
| ADAM15 → DLAT (>>) |
| ADAM15 → DNAJA4 (>>) |
| ADAM15 → EHD1 (>>) |
| ADAM15 → EPHA1 (>>) |
| ADAM15 → ERBB2 (>>) |
| ADAM15 → GNB2 (>>) |
| ADAM15 → HDAC11 (>>) |
| ADAM15 → KPNA1 (>>) |
| ADAM15 → MAP2K4 (>>) |
| ADAM15 → MEX3D (>>) |
| ADAM15 → MMP14 (>>) |
| ADAM15 → MVK (>>) |
| ADAM15 → ODZ2 (>>) |
| ADAM15 → PGK1 (>>) |
| ADAM15 → PIK3R3 (>>) |
| ADAM15 → PLD2 (>>) |
| ADAM15 → RAC1 (>>) |
| ADAM15 → RARG (>>) |
| ADAM15 → RXRG (>>) |
| ADAM15 → SHC1 (>>) |
| ADAM15 → SPR (>>) |
| ADAM15 → STK16 (>>) |
| ADAM15 → TARSL2 (>>) |
| ADAM15 → TK1 (>>) |
| ADAM15 → VPS37B (>>) |
